Frontiers of Hormone Research
Research Hotspot & Journal Scope - Hyperparathyroidism
Familial and Hereditary Forms of Primary Hyperparathyroidism.
F Cetani · F Saponaro · S Borsari · C Marcocci ·
MedicineFamilial Hypocalciuric Hypercalcemia and Neonatal Severe Hyperparathyroidism.
Letizia Vannucci · Maria Luisa Brandi ·
Biology MedicineObjective Tertiary hyperparathyroidism, an autonomous hyperproduction of parathyroid hormone (PTH), has a challenge in its treatment.
It is estimated that up to 90% of patients with chronic kidney disease develop secondary hyperparathyroidism (sHPT).
At present, the diagnosis and treatment standard of asymptomatic primary hyperparathyroidism is still controversial, This article is based on Guidelines for the management of asymptomatic primary hyperparathyroidism in 2014 and sharing the latest research progress to proved some suggestions for improving the medical management of asymptomatic primary hyperparathyroidism patients and improving the quality of life of them.
Medications that treat persistent hyperparathyroidism include vitamin D, vitamin D analogues, and calcimimetics.
An open label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis.
